Antec Medical's Disposable Intracardiac Mapping Catheter Receives NMPA Approval for Market Launch

Aug 13, 2024 16:27 CST Updated 16:27

Artechmed

Medical Device and Equipment Developer

On August 5, 2024, Artechmed (Shanghai An'erk Medical Technology Co., Ltd.) independently developed the "Single-Use Intracardiac Mapping Catheter"Product, obtained the certification issued by the National Medical Products Administration (NMPA)"Class III Medical DevicesRegistration Certificate, Approved for Marketing.

The disposable intracardiac mapping catheter approved this time is a circular mapping catheter, used for recording electrical potential signals within the pulmonary veins of the heart, and is suitable for atrial fibrillation.Electrophysiological Examination。

In addition to the standard models and specifications (15mm and 20mm), the disposable intracardiac mapping catheter approved this time also...Available in 25mm size.Large-size ring mapping catheter combined with short-tip cryoballoon catheter, in identifying largePulmonary VeinThe abnormal potential and accurate determination of TTI have prominent advantages.In addition, the ten-pole circular mapping catheter can more accurately identify pulmonary vein potentials, reduce far-field potential interference, help clinicians determine the endpoint of cryoablation, avoid under-ablation or over-ablation, and further improve the safety and efficiency of atrial fibrillation cryoablation procedures.

The approval and market launch of the disposable intracardiac mapping catheter will facilitate the formal clinical application of Artechmed's cardiac cryoablation system, meeting...The "Simplified Ablation" Clinical Needs in China's Atrial Fibrillation Ablation Treatment Field.

Artechmed was founded in 2017, with its headquarters located in the International Medical Park of Zhangjiang Science City, Shanghai, focusing on innovative solutions for cardiac electrophysiology diagnosis and treatment. The company has dual product technology platforms of Cryoballoon Ablation (CBA) and Pulsed Field Ablation (PFA), with dozens ofCore Independent Intellectual Property RightsThe core members all have extensive work experience in well-known medical device companies and possess rich experience in the research and development, production, clinical development, commercialization, and company operations of products in the fields of electrophysiological diagnosis and treatment, cardiovascular and cerebrovascular interventions, cryoablation, and active medical devices.